Abstract
The compounding of hydromorphone hydrochloride 20mg/ml and bupivacaine hydrochoride 7.5mg/ml injection is presented, including information on packaging, labeling, stability, quality control, and chemical properties of individual components.
Author supplied keywords
- Additives--sodium chloride;
- Anesthetics--bupivacaine hydrochloride;
- Bupivacaine hydrochloride--compounding-;
- Compounding--bupivacaine hydrochloride;
- Compounding--hydromorphone hydrochloride;
- Contraindications--bupivacaine hydrochloride;
- Contraindications--hydromorphone hydrochloride;
- Control, quality--bupivacaine hydrochloride;
- Control, quality--hydromorphone hydrochloride;
- Dosage--bupivacaine hydrochloride;
- Dosage--hydromorphone hydrochloride;
- Hydromorphone hydrochloride--compounding-;
- Injections--bupivacaine hydrochloride;
- Injections--hydromorphone hydrochloride;
- Labeling--bupivacaine hydrochloride;
- Labeling--hydromorphone hydrochloride;
- Opiate agonists--hydromorphone hydrochloride;
- Packaging--bupivacaine hydrochloride;
- Packaging--hydromorphone hydrochloride;
- Pain--bupivacaine hydrochloride;
- Sodium chloride--additives-;
- Toxicity--bupivacaine hydrochloride;
- Toxicity--hydromorphone hydrochloride;
Cite
CITATION STYLE
APA
Anonymous; (2004). Hydromorphone hydrochloride 20-mg/mL and bupivacaine hydrochloride 7.5-mg/mL injection. International Journal of Pharmaceutical Compounding (USA), 8(Feb), 136. Retrieved from http://search.ebscohost.com/login.aspx?direct=true&db=ipa&AN=41-10460&site=ehost-live
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free